These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
722 related articles for article (PubMed ID: 19418394)
1. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus? Borovicka J; Schönegg R; Hell M; Kradolfer D; Bauerfeind P; Dorta G; Netzer P; Binek J; Meyenberger C; Fischer JE; Spieler P Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394 [TBL] [Abstract][Full Text] [Related]
2. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study. Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320 [TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Cameron AJ; Carpenter HA Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304 [TBL] [Abstract][Full Text] [Related]
4. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102 [TBL] [Abstract][Full Text] [Related]
5. Benefit of baseline cytometry for surveillance of patients with Barrett's esophagus. Vogt N; Schönegg R; Gschossmann JM; Borovicka J Surg Endosc; 2010 May; 24(5):1144-50. PubMed ID: 19997751 [TBL] [Abstract][Full Text] [Related]
6. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963 [TBL] [Abstract][Full Text] [Related]
7. Brush cytology vs. endoscopic biopsy for the surveillance of Barrett's esophagus. Kumaravel A; Lopez R; Brainard J; Falk GW Endoscopy; 2010 Oct; 42(10):800-5. PubMed ID: 20821361 [TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
9. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769 [TBL] [Abstract][Full Text] [Related]
11. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552 [TBL] [Abstract][Full Text] [Related]
12. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Reid BJ; Blount PL; Feng Z; Levine DS Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322 [TBL] [Abstract][Full Text] [Related]
13. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. Isenberg G; Sivak MV; Chak A; Wong RC; Willis JE; Wolf B; Rowland DY; Das A; Rollins A Gastrointest Endosc; 2005 Dec; 62(6):825-31. PubMed ID: 16301020 [TBL] [Abstract][Full Text] [Related]
15. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Downs-Kelly E; Mendelin JE; Bennett AE; Castilla E; Henricks WH; Schoenfield L; Skacel M; Yerian L; Rice TW; Rybicki LA; Bronner MP; Goldblum JR Am J Gastroenterol; 2008 Sep; 103(9):2333-40; quiz 2341. PubMed ID: 18671819 [TBL] [Abstract][Full Text] [Related]
16. [Surveillance of patients with Barrett's esophagus]. Endlicher E; Knüchel R; Messmann H Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064 [TBL] [Abstract][Full Text] [Related]
17. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135 [TBL] [Abstract][Full Text] [Related]
18. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. O'Connor JB; Falk GW; Richter JE Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525 [TBL] [Abstract][Full Text] [Related]
19. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Harrison R; Perry I; Haddadin W; McDonald S; Bryan R; Abrams K; Sampliner R; Talley NJ; Moayyedi P; Jankowski JA Am J Gastroenterol; 2007 Jun; 102(6):1154-61. PubMed ID: 17433019 [TBL] [Abstract][Full Text] [Related]
20. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases. Padmavathy F; Siddaraju N; Sistla SC Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]